Search - tctmd.com

Displaying 321 - 340 of 353

Sort: Relevancy | Date

Presentation THT 2025

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Controlled Pulmonary Artery Banding for HFrEF (Restore Medical)

Presenter: Sean Pinney

February 12, 2025

Presentation THT 2025

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Presenter: Nir Uriel

February 12, 2025

Presentation THT Abstracts 2025

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Presenter: John Mohr

February 11, 2025

Presentation THT 2025

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Presenter: John Mohr

February 11, 2025

Presentation THT 2025

Will Novel Catheter Based Approaches Save the Day?

Presenter: Jaffar Khan

February 11, 2025

Presentation THT 2025

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Presenter: Giada Bianchi

February 11, 2025

Presentation THT 2025

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Presenter: Kavita Sharma

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Mechanical Circulatory Support for High-Risk PCI With a Novel VITALYST System: Early Feasibility and Safety Results of the VITALYST Study

Presenter: Kevin Croce

February 11, 2025

News Daily News

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

Michael O'Riordan

February 10, 2025

News Daily News

CVD Effects of Wildfire-Related Air Pollution Differ by Event

Yael L. Maxwell

February 10, 2025

News Daily News

Sexual Minorities See Sharpest Impact of SDOH on CV Health

Caitlin E. Cox

February 07, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

US Football Fans Are Flooded With Ads for Unhealthy Foods

Michael O'Riordan

January 30, 2025

News Industry News

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

January 30, 2025

Presentation Miami Valves 2025

Novel Device for Pulmonic Valve: Alterra

Presenter: Pedro Villablanca

January 30, 2025

Presentation Miami Valves 2025

VALFIX Novel Transcatheter Mitral Annuloplasty Repair

Presenter: Eberhard Grube

January 30, 2025

Presentation Miami Valves 2025

Novel TMVR Devices: CAPSTAN Medical

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Novel Vascular Closure Device (xDot) – First in Human Experience

Presenter: Adrian Ebner

January 30, 2025

Advertisement

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Controlled Pulmonary Artery Banding for HFrEF (Restore Medical)

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Will Novel Catheter Based Approaches Save the Day?

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Special Late-Breaking Clinical Science Abstract: Mechanical Circulatory Support for High-Risk PCI With a Novel VITALYST System: Early Feasibility and Safety Results of the VITALYST Study

High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada

CVD Effects of Wildfire-Related Air Pollution Differ by Event

Sexual Minorities See Sharpest Impact of SDOH on CV Health

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

US Football Fans Are Flooded With Ads for Unhealthy Foods

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

Novel Device for Pulmonic Valve: Alterra

VALFIX Novel Transcatheter Mitral Annuloplasty Repair

Novel TMVR Devices: CAPSTAN Medical

Novel Vascular Closure Device (xDot) – First in Human Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content